ArticleCanadian journal of surgery. Journal canadien de chirurgie
Evaluating variability in use of intravenous albumin in patients undergoing surgery for cancer.
Abstract read
In one paragraph
Article in Canadian journal of surgery. Journal canadien de chirurgie. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Jane YangFrom the Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ont. (Yang); Ontario Health (Cancer Care Ontario), Toronto, Ont. (Martin, Mak, Rashid, Hunter, Wright); Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, Ont. (Zhang, Callum); the Department of Anesthesia, University of Toronto, Toronto, Ont. (Bartoszko); the Institute of Health Policy Management and Evaluation, University of Toronto, Toronto, Ont. (Bartoszko, Zuckerman); the Division of General Surgery, Department of Surgery, University of Toronto, Toronto, Ont. (Zuckerman); the Department of Surgery, University of Toronto, Toronto, Ont. (Hallet, Wright); the Division of General Surgery, Sunnybrook Health Sciences Centre, Toronto, Ont. (Hallet, Wright); the Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ont. (Callum); the Department of Pathology and Molecular Medicine, Kingston Health Sciences Centre, Kingston, Ont. (Callum); the Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ont. (Callum).
Tharsiya MartinFrom the Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ont. (Yang); Ontario Health (Cancer Care Ontario), Toronto, Ont. (Martin, Mak, Rashid, Hunter, Wright); Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, Ont. (Zhang, Callum); the Department of Anesthesia, University of Toronto, Toronto, Ont. (Bartoszko); the Institute of Health Policy Management and Evaluation, University of Toronto, Toronto, Ont. (Bartoszko, Zuckerman); the Division of General Surgery, Department of Surgery, University of Toronto, Toronto, Ont. (Zuckerman); the Department of Surgery, University of Toronto, Toronto, Ont. (Hallet, Wright); the Division of General Surgery, Sunnybrook Health Sciences Centre, Toronto, Ont. (Hallet, Wright); the Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ont. (Callum); the Department of Pathology and Molecular Medicine, Kingston Health Sciences Centre, Kingston, Ont. (Callum); the Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ont. (Callum).
Victor MakFrom the Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ont. (Yang); Ontario Health (Cancer Care Ontario), Toronto, Ont. (Martin, Mak, Rashid, Hunter, Wright); Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, Ont. (Zhang, Callum); the Department of Anesthesia, University of Toronto, Toronto, Ont. (Bartoszko); the Institute of Health Policy Management and Evaluation, University of Toronto, Toronto, Ont. (Bartoszko, Zuckerman); the Division of General Surgery, Department of Surgery, University of Toronto, Toronto, Ont. (Zuckerman); the Department of Surgery, University of Toronto, Toronto, Ont. (Hallet, Wright); the Division of General Surgery, Sunnybrook Health Sciences Centre, Toronto, Ont. (Hallet, Wright); the Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ont. (Callum); the Department of Pathology and Molecular Medicine, Kingston Health Sciences Centre, Kingston, Ont. (Callum); the Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ont. (Callum).
Mohammed RashidFrom the Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ont. (Yang); Ontario Health (Cancer Care Ontario), Toronto, Ont. (Martin, Mak, Rashid, Hunter, Wright); Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, Ont. (Zhang, Callum); the Department of Anesthesia, University of Toronto, Toronto, Ont. (Bartoszko); the Institute of Health Policy Management and Evaluation, University of Toronto, Toronto, Ont. (Bartoszko, Zuckerman); the Division of General Surgery, Department of Surgery, University of Toronto, Toronto, Ont. (Zuckerman); the Department of Surgery, University of Toronto, Toronto, Ont. (Hallet, Wright); the Division of General Surgery, Sunnybrook Health Sciences Centre, Toronto, Ont. (Hallet, Wright); the Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ont. (Callum); the Department of Pathology and Molecular Medicine, Kingston Health Sciences Centre, Kingston, Ont. (Callum); the Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ont. (Callum).
Amber HunterFrom the Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ont. (Yang); Ontario Health (Cancer Care Ontario), Toronto, Ont. (Martin, Mak, Rashid, Hunter, Wright); Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, Ont. (Zhang, Callum); the Department of Anesthesia, University of Toronto, Toronto, Ont. (Bartoszko); the Institute of Health Policy Management and Evaluation, University of Toronto, Toronto, Ont. (Bartoszko, Zuckerman); the Division of General Surgery, Department of Surgery, University of Toronto, Toronto, Ont. (Zuckerman); the Department of Surgery, University of Toronto, Toronto, Ont. (Hallet, Wright); the Division of General Surgery, Sunnybrook Health Sciences Centre, Toronto, Ont. (Hallet, Wright); the Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ont. (Callum); the Department of Pathology and Molecular Medicine, Kingston Health Sciences Centre, Kingston, Ont. (Callum); the Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ont. (Callum).
Liying ZhangFrom the Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ont. (Yang); Ontario Health (Cancer Care Ontario), Toronto, Ont. (Martin, Mak, Rashid, Hunter, Wright); Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, Ont. (Zhang, Callum); the Department of Anesthesia, University of Toronto, Toronto, Ont. (Bartoszko); the Institute of Health Policy Management and Evaluation, University of Toronto, Toronto, Ont. (Bartoszko, Zuckerman); the Division of General Surgery, Department of Surgery, University of Toronto, Toronto, Ont. (Zuckerman); the Department of Surgery, University of Toronto, Toronto, Ont. (Hallet, Wright); the Division of General Surgery, Sunnybrook Health Sciences Centre, Toronto, Ont. (Hallet, Wright); the Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ont. (Callum); the Department of Pathology and Molecular Medicine, Kingston Health Sciences Centre, Kingston, Ont. (Callum); the Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ont. (Callum).
Justyna BartoszkoFrom the Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ont. (Yang); Ontario Health (Cancer Care Ontario), Toronto, Ont. (Martin, Mak, Rashid, Hunter, Wright); Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, Ont. (Zhang, Callum); the Department of Anesthesia, University of Toronto, Toronto, Ont. (Bartoszko); the Institute of Health Policy Management and Evaluation, University of Toronto, Toronto, Ont. (Bartoszko, Zuckerman); the Division of General Surgery, Department of Surgery, University of Toronto, Toronto, Ont. (Zuckerman); the Department of Surgery, University of Toronto, Toronto, Ont. (Hallet, Wright); the Division of General Surgery, Sunnybrook Health Sciences Centre, Toronto, Ont. (Hallet, Wright); the Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ont. (Callum); the Department of Pathology and Molecular Medicine, Kingston Health Sciences Centre, Kingston, Ont. (Callum); the Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ont. (Callum).
Jesse ZuckermanFrom the Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ont. (Yang); Ontario Health (Cancer Care Ontario), Toronto, Ont. (Martin, Mak, Rashid, Hunter, Wright); Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, Ont. (Zhang, Callum); the Department of Anesthesia, University of Toronto, Toronto, Ont. (Bartoszko); the Institute of Health Policy Management and Evaluation, University of Toronto, Toronto, Ont. (Bartoszko, Zuckerman); the Division of General Surgery, Department of Surgery, University of Toronto, Toronto, Ont. (Zuckerman); the Department of Surgery, University of Toronto, Toronto, Ont. (Hallet, Wright); the Division of General Surgery, Sunnybrook Health Sciences Centre, Toronto, Ont. (Hallet, Wright); the Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ont. (Callum); the Department of Pathology and Molecular Medicine, Kingston Health Sciences Centre, Kingston, Ont. (Callum); the Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ont. (Callum).
Julie HalletFrom the Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ont. (Yang); Ontario Health (Cancer Care Ontario), Toronto, Ont. (Martin, Mak, Rashid, Hunter, Wright); Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, Ont. (Zhang, Callum); the Department of Anesthesia, University of Toronto, Toronto, Ont. (Bartoszko); the Institute of Health Policy Management and Evaluation, University of Toronto, Toronto, Ont. (Bartoszko, Zuckerman); the Division of General Surgery, Department of Surgery, University of Toronto, Toronto, Ont. (Zuckerman); the Department of Surgery, University of Toronto, Toronto, Ont. (Hallet, Wright); the Division of General Surgery, Sunnybrook Health Sciences Centre, Toronto, Ont. (Hallet, Wright); the Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ont. (Callum); the Department of Pathology and Molecular Medicine, Kingston Health Sciences Centre, Kingston, Ont. (Callum); the Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ont. (Callum).
Frances C WrightFrom the Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ont. (Yang); Ontario Health (Cancer Care Ontario), Toronto, Ont. (Martin, Mak, Rashid, Hunter, Wright); Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, Ont. (Zhang, Callum); the Department of Anesthesia, University of Toronto, Toronto, Ont. (Bartoszko); the Institute of Health Policy Management and Evaluation, University of Toronto, Toronto, Ont. (Bartoszko, Zuckerman); the Division of General Surgery, Department of Surgery, University of Toronto, Toronto, Ont. (Zuckerman); the Department of Surgery, University of Toronto, Toronto, Ont. (Hallet, Wright); the Division of General Surgery, Sunnybrook Health Sciences Centre, Toronto, Ont. (Hallet, Wright); the Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ont. (Callum); the Department of Pathology and Molecular Medicine, Kingston Health Sciences Centre, Kingston, Ont. (Callum); the Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ont. (Callum).
Jeannie CallumFrom the Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ont. (Yang); Ontario Health (Cancer Care Ontario), Toronto, Ont. (Martin, Mak, Rashid, Hunter, Wright); Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, Ont. (Zhang, Callum); the Department of Anesthesia, University of Toronto, Toronto, Ont. (Bartoszko); the Institute of Health Policy Management and Evaluation, University of Toronto, Toronto, Ont. (Bartoszko, Zuckerman); the Division of General Surgery, Department of Surgery, University of Toronto, Toronto, Ont. (Zuckerman); the Department of Surgery, University of Toronto, Toronto, Ont. (Hallet, Wright); the Division of General Surgery, Sunnybrook Health Sciences Centre, Toronto, Ont. (Hallet, Wright); the Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ont. (Callum); the Department of Pathology and Molecular Medicine, Kingston Health Sciences Centre, Kingston, Ont. (Callum); the Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ont. (Callum) jeannie.callum@kingstonhsc.ca.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDespite numerous randomized controlled trials finding that albumin is not associated with improved patient outcomes, transfusion practice is highly variable. We examined the variability and impact of albumin transfusion on outcomes in cancer surgery.
methodsWe included consecutive adults undergoing cancer surgery between 2018 and 2021 in Ontario, Canada. The primary exposure was the proportion of patients who received perioperative albumin. The secondary outcomes were hospital length of stay and the incidence of infection, anemia, venous thromboembolism, and mortality in albumin-treated versus non-albumin-treated patients in a case-control analysis.
resultsOf 155 166 cancer surgeries (66.8% female patients, median age 62.9 yr), 2.5% received perioperative albumin. The cancer surgery types with the highest proportion of patients receiving albumin were hepato-pancreato-biliary (24.8%) and colorectal (18.6%). Of 104 facilities, 12.5% had nonrandom outliers for albumin use in at least 1 cancer type (
conclusionAlbumin transfusion rates were highly variable among hospitals for the same cancer type. Quality improvement initiatives are warranted to curtail unnecessary albumin transfusions in the perioperative period.
Indexed as
AlbuminsBlood TransfusionNeoplasmsPerioperative CarePostoperative ComplicationsAgedCase-Control StudiesFemaleHumansLength of StayMaleMiddle AgedOntarioRetrospective StudiesAlbumins
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.